Sandra Waugh Ruggles, PhD, Sandra serves as director for policy research in the Stanford Biodesign Policy Program. She studies policy issues at the intersection of healthcare and innovation. She also is the President of Summit Rock Strategy Consulting where she specializes in leading medtech development teams through early-stage innovation decisions. Sandra has over 20 years of experience in medical device and biotechnology innovation, leading projects for next-generation and breakthrough products in various domains, from consumer devices to therapeutic proteins. Sandra was named a Top Innovator Under 35 by MIT Technology Review for her work in co-founding Catalyst Biosciences. She earned a PhD from the University of California, San Francisco in biophysics and was a Stanford Biodesign Innovation Fellow.